Lloyd's Market Association Bulletin

LMA20-033-PD | 06 July 2020

Contingency Coronavirus and Communicable Disease Exclusions

The LMA Contingency Business Panel has published the attached model exclusions:

   LMA5507 Contingency Coronavirus Exclusion
   LMA5508 Communicable Disease Exclusion (For use on Contingency Cancellation & Abandonment risks) 
   LMA5509 Communicable Disease Exclusion (For use on Contingency Non-Appearance risks)

 

As with all LMA model clauses, these exclusions are purely illustrative and are distributed for the guidance of LMA members, who are free to agree to different conditions or amend as they see fit.

These exclusions are available on the Lloyd’s Wordings Repository (LWR), which can be accessed via www.lloydswordings.com. The LMA has already published the following model clauses: a Coronavirus Exclusion (LMA5391), which emanated from the Personal Accident market (Accident & Health); a Communicable Disease Endorsement (LMA5393) for use on property contracts; a Communicable Disease Exclusion (LMA5394) for use on property treaty reinsurance contracts; a Coronavirus Exclusion (LMA5395) for use on marine and energy liability contracts; a Communicable Disease Exclusion (LMA5396) for use on liability policies; a Communicable Disease Exclusion (LMA5397) for use on power generation, construction and engineering policies; an Infectious or Contagious Disease Exclusion (LMA5398), for use on UK consumer and commercial property risks; a Communicable Disease Exclusion (LMA5399), for use on casualty treaty reinsurance; an Infectious or Contagious Disease Exclusion during a declared Public Health Emergency (LMA5500), for use on consumer and commercial accident/accident & illness policies; a Political Risk Communicable Disease Exclusion (LMA5501); three Limited Communicable Disease Exclusions (LMA5502, LMA5503 and LMA5505), for use on property treaty reinsurance; an Occupational Disease and Cumulative Trauma Endorsement (LMA5504), for use on reinsurance agreements covering workers’ compensation business in the US; and a Communicable Disease Endorsement (for use on US Errors & Omissions policies) (LMA5506). The LMA continues to work with various Business Panels/Committees who have requested variants of the coronavirus clause and/or communicable disease language for their class of business.

The LMA is, as usual, aiming for a common format/structure and consistency of language across LMA model clauses drafted in response to COVID-19. Any queries regarding these exclusions should be referred to the LMA.

Contacts

Patrick Davison
Deputy Director of Underwriting
patrick.davison@lmalloyds.com

Alison Colver
Head of Contract Wordings
alison.colver@lmalloyds.com

Ioanna Romanou
Senior Technical Executive, Underwriting
ioanna.romanou@lmalloyds.com